Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Operating Leases (2019 - 2025)

Bio-Techne has reported Operating Leases over the past 7 years, most recently at $77.2 million for Q4 2025.

  • Quarterly results put Operating Leases at $77.2 million for Q4 2025, down 5.43% from a year ago — trailing twelve months through Dec 2025 was $77.2 million (down 5.43% YoY), and the annual figure for FY2025 was $84.0 million, down 4.17%.
  • Operating Leases for Q4 2025 was $77.2 million at Bio-Techne, down from $80.7 million in the prior quarter.
  • Over the last five years, Operating Leases for TECH hit a ceiling of $97.3 million in Q3 2023 and a floor of $56.3 million in Q1 2022.
  • Median Operating Leases over the past 5 years was $80.1 million (2025), compared with a mean of $78.2 million.
  • Biggest five-year swings in Operating Leases: dropped 15.67% in 2022 and later surged 65.52% in 2023.
  • Bio-Techne's Operating Leases stood at $57.7 million in 2021, then surged by 35.46% to $78.2 million in 2022, then grew by 22.82% to $96.0 million in 2023, then decreased by 15.01% to $81.6 million in 2024, then decreased by 5.43% to $77.2 million in 2025.
  • The last three reported values for Operating Leases were $77.2 million (Q4 2025), $80.7 million (Q3 2025), and $84.0 million (Q2 2025) per Business Quant data.